Comparing two pain management techniques for lung cancer surgery
Analgesic Effect of Mid-transverse Process to Pleura Block Combined With Erector Spinae Block Versus Paravertebral Plane Block in Thoracic Surgery for Lung Cancer Patients
This study is testing two different pain management techniques for lung cancer surgery to see which one helps patients feel better with less discomfort after their operation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06618599 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of the Mid-transverse process to pleura block combined with erector spinae block against the traditional paravertebral plane block in patients with lung cancer undergoing thoracotomy surgeries. The Mid-transverse process to pleura block is a less invasive technique that targets the paravertebral space through a specific needle placement, while the erector spinae block provides analgesia to the thoracoabdominal region. The study will evaluate postoperative pain management outcomes to determine which method offers better relief and fewer side effects.
Who should consider this trial
Good fit: Ideal candidates are lung cancer patients aged 18 to 65 with a BMI between 20 and 35, classified as ASA II or III.
Not a fit: Patients with severe comorbidities, contraindications to regional anesthesia, or those outside the specified age and BMI range may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for lung cancer patients undergoing surgery.
How similar studies have performed: Other studies have shown promising results with similar regional anesthesia techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * lung cancer patients for thoracotomy surgeries. * Physical status American Society of Anesthesiologists (ASA )II, III. * Age ≥ 18 and ≤ 65 Years. * Body mass index (BMI): \> 20 kg/m2 and \< 35 kg/m2 Exclusion Criteria: * Patient refusal * physical status ASA IV, * Age \<18 years or \>65 years * BMI \< 20 kg/m2 and \>35 kg/m2 * Known sensitivity or contraindication to drug used in the study (local anesthetics, opioids). * History of psychological disorders and/or chronic pain. * Contraindication to regional anesthesia e.g., local sepsis, pre- existing peripheral neuropathies, and coagulopathy. * Severe respiratory, cardiac, hepatic or renal disease.
Where this trial is running
Cairo
- Cairo University — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: sayed M Abed — Cairo University
- Study coordinator: sayed M abed, MD degree
- Email: sydabed2020@outlook.com
- Phone: +201226806532
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.